Clinical trials
Lupus Nephritis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
113 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 6 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 8 |
| 2023 | 8 |
| 2024 | 16 |
| 2025 | 14 |
| 2026 | 14 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 33 |
| Completed | 32 |
| Terminated | 21 |
| Active, not recruiting | 12 |
| Withdrawn | 10 |
| Enrolling by invitation | 3 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aurinia Pharmaceuticals Inc. | 7 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 5 |
| Novartis Pharmaceuticals | 5 |
| Hoffmann-La Roche | 4 |
| AstraZeneca | 3 |
| Biogen | 3 |
| Bristol-Myers Squibb | 3 |
| La Jolla Pharmaceutical Company | 3 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 3 |
| The Rogosin Institute | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Nephritis | 113 |
| Lupus Erythematosus, Systemic | 53 |
| Autoimmune Diseases | 15 |
| Scleroderma, Systemic | 14 |
| Myositis | 10 |
| Scleroderma, Diffuse | 8 |
| Glomerulonephritis | 7 |
| Glomerulonephritis, IGA | 7 |
| Nephritis | 7 |
| Dermatomyositis | 6 |
Trials
Showing 1 to 25 of 113. Each trial links to its page on Pharma Observatory.
13 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.